Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current understanding of cancer-intrinsic PD-L1: regulation of expression and its protumoral activity
Pedram Yadollahi, Youkyoung Jeon, Wooi Loon Ng, et al.
BMB Reports (2021) Vol. 54, Iss. 1, pp. 12-20
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

EGFR signaling pathway as therapeutic target in human cancers
Elena Levantini, Giorgia Maroni, Marzia Del Re, et al.
Seminars in Cancer Biology (2022) Vol. 85, pp. 253-275
Open Access | Times Cited: 181
The role of p53 in anti-tumor immunity and response to immunotherapy
Lindsey Carlsen, Shengliang Zhang, Xiaobing Tian, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 39
Engineered biological nanoparticles as nanotherapeutics for tumor immunomodulation
Juwita N. Rahmat, Jiayi Liu, Taili Chen, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 11, pp. 5862-5903
Open Access | Times Cited: 11
Development of natural products for anti-PD-1/PD-L1 immunotherapy against cancer
MyongHak Ri, Juan Ma, Xuejun Jin
Journal of Ethnopharmacology (2021) Vol. 281, pp. 114370-114370
Closed Access | Times Cited: 35
Recent Advancement of PD-L1 Detection Technologies and Clinical Applications in the Era of Precision Cancer Therapy
Yuanfeng Zhang, Juanjuan Wu, Chaobin Zhao, et al.
Journal of Cancer (2023) Vol. 14, Iss. 5, pp. 850-873
Open Access | Times Cited: 16
STING mediates nuclear PD-L1 targeting-induced senescence in cancer cells
Je‐Jung Lee, So Young Kim, Songhee H. Kim, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 22
PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia
Mojdeh Soltani, Mustafa Ghanadian, Behrooz Ghezelbash, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 12
The Role of Regulatory T Cells in Cancer Treatment Resistance
Anna Dąbrowska, Magdalena Grubba, Amar Balihodzic, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14114-14114
Open Access | Times Cited: 11
Next-generation sequencing: unraveling genetic mechanisms that shape cancer immunotherapy efficacy
Ahmed Halima, Winston Vuong, Timothy A. Chan
Journal of Clinical Investigation (2022) Vol. 132, Iss. 12
Open Access | Times Cited: 18
Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling Strategy
Kaizhen Wang, Xiangyu Zhang, Yao Cheng, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 24, pp. 16807-16827
Closed Access | Times Cited: 10
PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD)
Stefania Angelicola, Francesca Giunchi, Francesca Ruzzi, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Programmed death-ligand 1 regulates ameloblastoma growth and recurrence
Linzhou Zhang, Hao Lin, Jiajie Liang, et al.
International Journal of Oral Science (2025) Vol. 17, Iss. 1
Open Access
Genomic profiling informs therapies and prognosis for patients with hepatocellular carcinoma in clinical practice
Mengqi Song, Haoyue Cheng, Hao Zou, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
The programmed death ligand 1 interactome demonstrates bidirectional signaling coordinating immune suppression and cancer progression in head and neck squamous cell carcinoma
Cera Nieto, Bettina Miller, Nathaniel Alzofon, et al.
JNCI Journal of the National Cancer Institute (2023) Vol. 115, Iss. 11, pp. 1392-1403
Open Access | Times Cited: 7
The Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Breast Cancer Are Regulated by N-Linked Glycosylation-Dependent Activation of STAT3 and STAT1
Nofar Erlichman, Tsipi Meshel, Tamir Baram, et al.
Cells (2023) Vol. 12, Iss. 19, pp. 2338-2338
Open Access | Times Cited: 6
Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) pathway
Lili Song, Shikai Liu, Sufen Zhao
Bioengineered (2022) Vol. 13, Iss. 4, pp. 11240-11257
Open Access | Times Cited: 10
Tumor-Intrinsic PD-L1 Exerts an Oncogenic Function through the Activation of the Wnt/β-Catenin Pathway in Human Non-Small Cell Lung Cancer
Yunxia Ma, Rumyana Marinkova, Miljana Nenkov, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11031-11031
Open Access | Times Cited: 9
Impact of spatial metabolomics on immune-microenvironment in oral cancer prognosis: a clinical report
Swarnendu Bag, Janina Oetjen, Soni Shaikh, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 1, pp. 41-49
Closed Access | Times Cited: 5
PD-L1 Mediates IFNγ-Regulation of Glucose but Not of Tryptophan Metabolism in Clear Cell Renal Cell Carcinoma
Mamatha Garige, Susmita Ghosh, Alexis L. Norris, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Perspectives on immune checkpoint ligands: expression, regulation, and clinical implications
Jihyun Moon, Yoo Min Oh, Sang‐Jun Ha
BMB Reports (2021) Vol. 54, Iss. 8, pp. 403-412
Open Access | Times Cited: 10
Tumor immune microenvironment in odontogenic carcinomas: Evaluation of the therapeutic potential of immune checkpoint blockade
Kyu‐Young Oh, Seong‐Doo Hong, Hye‐Jung Yoon
Journal of Oral Pathology and Medicine (2024) Vol. 53, Iss. 3, pp. 217-225
Closed Access | Times Cited: 1
Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care
Shi‐Ming Tu, Anup Kumar Trikannad, Sruthi Vellanki, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1151-1151
Open Access | Times Cited: 1
Protein Kinase C Alpha is a Central Node for Tumorigenic Transcriptional Networks in Human Prostate Cancer
Mariana Cooke, Xuyao Zhang, Suli Zhang, et al.
Cancer Research Communications (2022) Vol. 2, Iss. 11, pp. 1372-1387
Open Access | Times Cited: 6
Targeting tumor-intrinsic PD-L1 suppresses the progression and aggressiveness of head and neck cancer by inhibiting GSK3β-dependent Snail degradation
Chi‐Hyun Ahn, Kyu‐Young Oh, Bohwan Jin, et al.
Cellular Oncology (2022) Vol. 46, Iss. 2, pp. 267-282
Closed Access | Times Cited: 6
Current Status and Molecular Mechanisms of Resistance to Immunotherapy in Oral Malignant Melanoma
Sena Zeynep Usta, Toshihiro Uchihashi, Shingo Kodama, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17282-17282
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top